Study finds manufacturers spend more to advertise less beneficial drugs

A recent study published in the Journal of the American Medical Association (JAMA) found that drugmakers spent more money marketing drugs with lower added benefit in 2020, and the amount of direct-to-consumer (DTC) advertising spending rose with increased drug sales.